Targetedonc
1 known investors
Find your way into Targetedonc
Sign up to see every warm intro you have to Targetedonc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Targetedonc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Targeted Oncology is a medical news and education publication for oncologists and cancer care professionals, covering clinical trial data, FDA approvals, treatment guidelines, and expert commentary across cancer types. It delivers conference coverage, podcasts, videos, and short-form content focused on precision oncology and targeted cancer therapies.
Investors · 1
Frequently asked questions
- What does Targetedonc do?
- Targeted Oncology is a medical news and education publication for oncologists and cancer care professionals, covering clinical trial data, FDA approvals, treatment guidelines, and expert commentary across cancer types. It delivers conference coverage, podcasts, videos, and short-form content focused on precision oncology and targeted cancer therapies.
- Who are Targetedonc's investors?
- Targetedonc's investors include Angel Physicians Fund.
